Donald A. Kalkofen, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), bought 1,175 shares at $5.10 ($6K) on 2019-12-03, disclosed to the SEC on 2019-12-03.
Open-market purchase of $6k PTGX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.09 | 562 | $3K | 47.8% |
| 2 | $5.10 | 613 | $3K | 52.2% |
| Total | $5.10 avg | 1,175 | $6K | 100% |